May 15, 2017 / 8:15 PM / 2 months ago

BRIEF-Editas Medicine Q1 loss per share $0.85

1 Min Read

May 15 (Reuters) - Editas Medicine Inc:

* Editas Medicine announces first quarter 2017 results and update

* Q1 loss per share $0.85

* Q1 earnings per share view $-0.61 -- Thomson Reuters I/B/E/S

* Editas Medicine Inc - target date for filing ind application for LCA10 program is being moved to middle of 2018

* Editas Medicine Inc - research and development expenses were $19.0 million for quarter ended March 31, 2017, compared to $8.9 million for same period in 2016 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below